throbber
9/18/2019
`
`A pill for relapsing MS | Tecfidera® (dimethyl fumarate)
`
`Important Safety Information
`
`Patient Information & Prescribing Information
`
`*Based on prescriptions.
`
`opens up possibilities
`
`Laura S., living with relapsing MS
`

`Tecfidera (dimethyl fumarate) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically
`isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
`
`*Based on number of prescriptions from IMS NPA™ Weekly Data
`(September 27, 2013 – March 29, 2019).
`IMPORTANT SAFETY INFORMATION AND INDICATION
`
`https://www.tecfidera.com
`
`EXPAND
`
`1/7
`
`MYLAN PHARMS. INC. EXHIBIT 1096 PAGE 1
`
`

`

`9/18/2019
`
`A pill for relapsing MS | Tecfidera® (dimethyl fumarate)
`
`TECFIDERA
`effectiveness
`
`❯
`
`
`
`Prepare for
`your next visit
`
`❯
`
`Where could yes take you?
`Say yes to TECFIDERA—a twice-daily pill for relapsing MS
`that was shown to be effective in 3 different ways:
`
`Cut
`RELAPSES
`IN HALF
`*
`
`Know more ❯
`
`In 2
`*
`separate
`two-year
`studies,
`compared
`with
`placebo,
`TECFIDERA
`reduced
`risk of
`relapse by
`49% and
`34%, and
`reduced
`number of
`relapses by
`53% and
`44%.
`
`Delay
`PROGRESSION
`OF
`PHYSICAL DISABILITY
`
`Discover how ❯
`
`Slow
`DEVELOPMENT
`OF BRAIN LESIONS
`
`Get the details ❯
`
`In 2 separate two-year studies, compared with placebo, TECFIDERA reduced risk of relapse by 49% and 34%,
`*
`and reduced number of relapses by 53% and 44%, respectively.
`
`TECFIDERA has up to 10 years of combined clinical trial and real-world experience. Learn about TECFIDERA
`†
`
`Based on data on file.
`
`† S
`
`tay connected
`Get the latest information from MS experts and hear from others who have taken TECFIDERA.
`
`Sign Up ❯
`
`IMPORTANT SAFETY INFORMATION AND INDICATION
`
`https://www.tecfidera.com
`
`EXPAND
`
`2/7
`
`MYLAN PHARMS. INC. EXHIBIT 1096 PAGE 2
`
`

`

`9/18/2019
`
`A pill for relapsing MS | Tecfidera® (dimethyl fumarate)
`
`IMPORTANT SAFETY INFORMATION AND INDICATION
`
`https://www.tecfidera.com
`
`EXPAND
`
`3/7
`
`MYLAN PHARMS. INC. EXHIBIT 1096 PAGE 3
`
`

`

`9/18/2019
`
`A pill for relapsing MS | Tecfidera® (dimethyl fumarate)
`
`Personal stories
`People living with relapsing multiple sclerosis (MS) have a lot to share. Learn about their struggles, lessons, victories, and why they
`IMPORTANT SAFETY INFORMATION AND INDICATION
`EXPAND
`
`https://www.tecfidera.com
`
`4/7
`
`MYLAN PHARMS. INC. EXHIBIT 1096 PAGE 4
`
`

`

`9/18/2019
`
`said yes to TECFIDERA.
`
`A pill for relapsing MS | Tecfidera® (dimethyl fumarate)
`
`See their stories ❯
`Antonia S.,
`living with relapsing MS
`
`We also recommend
`
`Questions to ask your healthcare provider while on TECFIDERA
`
`Start here ❯
`
`Could you be eligible for the $0 Copay Program?
`IMPORTANT SAFETY INFORMATION AND INDICATION
`
`https://www.tecfidera.com
`
`EXPAND
`
`5/7
`
`MYLAN PHARMS. INC. EXHIBIT 1096 PAGE 5
`
`

`

`9/18/2019
`
`A pill for relapsing MS | Tecfidera® (dimethyl fumarate)
`
`Find out now ❯
`
`Newly diagnosed?
`TECFIDERA may help
`
`Learn more ❯
`
`IMPORTANT SAFETY INFORMATION
`Do not use Tecfidera (dimethyl fumarate) if you have had an allergic reaction (such as welts, hives, swelling of the face, lips, mouth or

`tongue, or difficulty breathing) to TECFIDERA or any of its ingredients.
`
`Before taking and while you take TECFIDERA, tell your healthcare provider about any low white blood cell counts or infections or any other
`medical conditions. 
`
`What are the possible side effects of TECFIDERA?
`
`TECFIDERA may cause serious side effects including:
`Allergic reactions
`PML, which is a rare brain infection that usually leads to death or severe disability.
`Decreases in your white blood cell count. Your healthcare provider should check your white blood cell count before you take TECFIDERA
`and from time to time during treatment
`Liver problems. Your healthcare provider should do blood tests to check your liver function before you start taking TECFIDERA and
`during treatment if needed. Tell your healthcare provider right away if you get any symptoms of a liver problem during treatment,
`including:
`severe tiredness
`loss of appetite
`pain on the right side of your stomach
`dark or brown (tea color) urine
`yellowing of your skin or the white part of your eyes
`
`The most common side effects of TECFIDERA include flushing and stomach problems. These can happen especially at the start of
`treatment and may decrease over time. Taking TECFIDERA with food may help reduce flushing. Call your healthcare provider if these
`symptoms bother you or do not go away. Ask your healthcare provider if taking aspirin before taking TECFIDERA may reduce flushing.
`
`These are not all the possible side effects of TECFIDERA. Call your healthcare provider for medical advice about side effects. You may
`IMPORTANT SAFETY INFORMATION AND INDICATION
`report side effects to FDA at 1-800-FDA-1088. For more information go to dailymed.nlm.nih.gov.
`EXPAND
`
`https://www.tecfidera.com
`
`6/7
`
`MYLAN PHARMS. INC. EXHIBIT 1096 PAGE 6
`
`

`

`9/18/2019
`A pill for relapsing MS | Tecfidera® (dimethyl fumarate)
`Tell your healthcare provider if you are pregnant or plan to become pregnant, or breastfeeding or plan to breastfeed. It is not known if
`TECFIDERA will harm your unborn baby or if it passes into your breast milk. Also tell your healthcare provider if you are taking prescription
`or over-the-counter medicines, vitamins, or herbal supplements. If you take too much TECFIDERA, call your healthcare provider or go to
`the nearest hospital emergency room right away.
`
`Please see full Prescribing Information and Patient Information.
`
`This is not intended to replace discussions with your healthcare provider.
`
`Indication
`Tecfidera (dimethyl fumarate) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically

`isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
`
`WHAT IS TECFIDERA?
`
`Effectiveness
`
`Safety
`
`Talking to your healthcare provider
`
`STARTING TECFIDERA
`
`Dosage
`
`Common side effects
`
`Staying on track
`
`SUPPORT & EVENTS
`
`Support program
`
`Financial & insurance information
`
`Find events
`
`What is relapsing MS?
`
`Resources for care partners
`
`PERSONAL STORIES
`
`Living with relapsing MS
`
`SIGN UP
`
`EN ESPAÑOL
`
`© 2019 Biogen. All rights reserved.
`This site is intended for residents 18 years or older of the United States, Puerto Rico, and US territories.
`All trademarks are the property of their respective owners.
`
`Terms of Use
`| Privacy Policy
`| Contact Us
`| Site Map
`| Unsubscribe
`Sign Up
`
`IMPORTANT SAFETY INFORMATION AND INDICATION
`
`https://www.tecfidera.com
`
`EXPAND
`
`7/7
`
`MYLAN PHARMS. INC. EXHIBIT 1096 PAGE 7
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket